Meldungen zum Thema Enterprises

Folgen
Keine Meldung zum Thema Enterprises mehr verpassen.
Filtern
  • 05.09.2011 – 02:02

    BNK Petroleum Inc.

    BNK Petroleum Inc. Baltic Basin Update

    Camarillo, California (ots/PRNewswire) - BNK Petroleum Inc. (the "Company") , on behalf of Saponis Investments Sp z o.o, announced today that it has received additional data from the Lebork S-1 and Wytowno S-1 wells drilled on the adjacent Slawno and Slupsk concessions. The new data from the third party contractors consists of the total organic carbons ("TOCs") for the three target intervals in the Lebork S-1 well and ...

  • 02.09.2011 – 14:02

    Perimeter Institute for Theoretical Physics

    Africa's Math and Science Stars to Shine at New Centre in Senegal

    Mbour, Senegal (ots/PRNewswire) - Mathematics underpins science, technology and modern society - from cell phones to computers and satellites. On September 6, 2011, the Government of Senegal led by His Excellency President Abdoulaye Wade and international partners will open a new pan-African centre of excellence for Africa's brightest math and science graduates, in a beautiful seaside location in Mbour, 80 km south of ...

  • 01.09.2011 – 13:32

    Burcon NutraScience Corporation

    Burcon Files NASDAQ Listing Application

    Vancouver, Canada (ots/PRNewswire) - Burcon NutraScience Corporation ("Burcon" or the "Company") is pleased to announce that it has filed an application to list its common shares on the NASDAQ Stock Market LLC and has filed a registration statement to register its common shares on Form 40-F with the United States Securities and Exchange Commission (the "SEC"), pursuant to section 12 of the United States Securities ...

  • 01.09.2011 – 11:00

    Pevion Biotech AG

    Pevion grants CSL option right to its therapeutic Candida vaccine

    Ittigen/Bern, Switzerland (ots) - Pevion Biotech AG today announced that the company has granted to CSL Limited a right of first refusal for the commercialization of its therapeutic Candida vaccine in Australia and New Zealand. At the same time, both companies signed a long-term supply agreement under which CSL shall supply to Pevion components for its virosomal vaccines. CSL, Australia's leading biopharmaceutical ...